Information:
Fel:
ID
28270
Beskrivning
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Study part: Prior + concomitant diseases. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Nyckelord
Versioner (2)
- 2017-12-07 2017-12-07 -
- 2018-01-01 2018-01-01 -
Rättsinnehavare
Prof. Dr. med. Georg Heß
Uppladdad den
1 januari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Diseases GOAL Trial B-cell Lymphoma NCT02499003
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Diseases GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
medical conditions
Item
Are there any relevant medical conditions?
boolean
C0012634 (UMLS CUI [1])
Disease number
Item
No.
integer
C0750480 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,2])
specification
Item
Disease, specify term:
text
C2348235 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
Stop date
Item
Stop date
date
C0806020 (UMLS CUI [1])
Ongoing disease End of Treatment
Item
Ongoing at End of Treatment?
boolean
C0549178 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0580352 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,2])
C0580352 (UMLS CUI [1,3])